Free Trial

Vontier (VNT) Competitors

Vontier logo
$37.76 -0.87 (-2.24%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$37.71 -0.05 (-0.12%)
As of 02/21/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VNT vs. TER, RVTY, AVTR, BIO.B, NVMI, ST, CAMT, MIR, TXG, and TRNS

Should you be buying Vontier stock or one of its competitors? The main competitors of Vontier include Teradyne (TER), Revvity (RVTY), Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Sensata Technologies (ST), Camtek (CAMT), Mirion Technologies (MIR), 10x Genomics (TXG), and Transcat (TRNS). These companies are all part of the "measuring and control equipment" industry.

Vontier vs.

Teradyne (NASDAQ:TER) and Vontier (NYSE:VNT) are both computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership, risk, community ranking and media sentiment.

In the previous week, Vontier had 9 more articles in the media than Teradyne. MarketBeat recorded 18 mentions for Vontier and 9 mentions for Teradyne. Teradyne's average media sentiment score of 1.45 beat Vontier's score of 0.82 indicating that Teradyne is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teradyne
6 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Vontier
8 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Teradyne received 33 more outperform votes than Vontier when rated by MarketBeat users. However, 51.76% of users gave Vontier an outperform vote while only 46.67% of users gave Teradyne an outperform vote.

CompanyUnderperformOutperform
TeradyneOutperform Votes
77
46.67%
Underperform Votes
88
53.33%
VontierOutperform Votes
44
51.76%
Underperform Votes
41
48.24%

99.8% of Teradyne shares are owned by institutional investors. Comparatively, 95.8% of Vontier shares are owned by institutional investors. 0.4% of Teradyne shares are owned by company insiders. Comparatively, 0.8% of Vontier shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Teradyne has higher earnings, but lower revenue than Vontier. Vontier is trading at a lower price-to-earnings ratio than Teradyne, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teradyne$2.82B6.69$542.37M$3.3334.81
Vontier$2.98B1.88$422.20M$2.7513.73

Teradyne has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500. Comparatively, Vontier has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500.

Teradyne pays an annual dividend of $0.48 per share and has a dividend yield of 0.4%. Vontier pays an annual dividend of $0.10 per share and has a dividend yield of 0.3%. Teradyne pays out 14.4% of its earnings in the form of a dividend. Vontier pays out 3.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Teradyne presently has a consensus price target of $143.77, indicating a potential upside of 24.04%. Vontier has a consensus price target of $45.43, indicating a potential upside of 20.32%. Given Teradyne's stronger consensus rating and higher possible upside, analysts plainly believe Teradyne is more favorable than Vontier.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teradyne
1 Sell rating(s)
2 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.79
Vontier
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Teradyne has a net margin of 19.23% compared to Vontier's net margin of 14.17%. Vontier's return on equity of 43.22% beat Teradyne's return on equity.

Company Net Margins Return on Equity Return on Assets
Teradyne19.23% 19.08% 14.47%
Vontier 14.17%43.22%10.38%

Summary

Teradyne beats Vontier on 15 of the 21 factors compared between the two stocks.

Get Vontier News Delivered to You Automatically

Sign up to receive the latest news and ratings for VNT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VNT vs. The Competition

MetricVontierFluid meters & counting devices IndustryBusiness SectorNYSE Exchange
Market Cap$5.61B$5.90B$7.81B$20.07B
Dividend Yield0.25%0.44%2.20%3.65%
P/E Ratio13.7331.7033.8534.89
Price / Sales1.884.6867.5215.65
Price / Cash10.5825.9132.3120.85
Price / Book5.307.755.424.92
Net Income$422.20M$273.57M$187.27M$1.02B
7 Day Performance-3.98%-3.57%-2.92%-1.05%
1 Month Performance-2.04%-2.97%-1.50%-1.09%
1 Year Performance-11.37%11.65%18.50%13.71%

Vontier Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VNT
Vontier
3.9724 of 5 stars
$37.76
-2.2%
$45.43
+20.3%
-9.4%$5.61B$2.98B13.738,000Analyst Forecast
High Trading Volume
TER
Teradyne
4.9477 of 5 stars
$113.25
+0.4%
$143.77
+26.9%
+16.4%$18.44B$2.82B34.016,500Analyst Revision
Positive News
RVTY
Revvity
4.019 of 5 stars
$112.34
-0.5%
$136.25
+21.3%
+9.6%$13.67B$2.76B50.8311,500Positive News
AVTR
Avantor
4.9027 of 5 stars
$17.87
-1.3%
$25.92
+45.1%
-29.1%$12.16B$6.97B38.8414,500Short Interest ↓
BIO.B
Bio-Rad Laboratories
N/A$312.05
flat
N/A-11.6%$8.74B$2.67B-11.428,200
NVMI
Nova
1.2832 of 5 stars
$267.97
-0.4%
$246.67
-7.9%
+69.8%$7.78B$517.92M49.993,606
ST
Sensata Technologies
4.6291 of 5 stars
$29.57
+2.5%
$39.08
+32.2%
-13.7%$4.42B$4.05B-54.7619,400
CAMT
Camtek
4.4099 of 5 stars
$86.82
-1.9%
$114.11
+31.4%
-0.9%$3.94B$315.38M40.01400
MIR
Mirion Technologies
2.1759 of 5 stars
$16.32
+0.4%
$19.25
+17.9%
+61.7%$3.79B$800.90M-48.013,000
TXG
10x Genomics
4.3998 of 5 stars
$12.31
+3.1%
$20.57
+67.1%
-76.6%$1.49B$610.79M-8.051,240Analyst Forecast
High Trading Volume
TRNS
Transcat
3.7529 of 5 stars
$84.85
+1.5%
$111.50
+31.4%
-23.3%$789.95M$259.48M45.861,104Positive News

Related Companies and Tools


This page (NYSE:VNT) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners